Related Experiment Video
Updated: Jul 2, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
BODIPY Photocage-Based Injectable Hydrogel for Light-Controlled Nanoparticle Release
Baihao Shao1,2, David J Peeler1,2,3, Thomas F F Fernandez Debets1
1Department of Physiology, Anatomy and Genetics, Department of Engineering Science and Kavli Institute for Nanoscience Discovery, University of Oxford, Oxford, UK.
Abstract:
Light-controlled release of therapeutics holds great promise for improving patient compliance with treatment plans against many leading diseases and could contribute to a better quality of life for people suffering from chronic conditions. However, insufficient tissue penetration of light largely limits the in vivo applications of photoresponsive therapeutics. With the aim to circumvent this limitation and to work within tissue depths that are pragmatically accessible to light, we developed an injectable and photodegradable hydrogel that could enable controlled drug delivery in subcutaneous tissue. In this work, we describe a hydrogel formulation consisting of a 2-arm photocage bearing azide and a BCN-terminated 4-arm PEG. Gelation takes place in minutes upon mixing the two components via strain-promoted azide-alkyne cycloaddition (SPAAC). Both gel precursors are made water-soluble and exhibit low viscosity prior to complete gelation, and the pre-gel is easily injectable through 23G needles. Photocage photocleavage and consequent gel degradation could be precisely controlled with green light irradiation. We further showed that nanoparticles can be successfully encapsulated into the gel and subsequently photo-released. The full operation process was demonstrated in an ex vivo porcine model and the acute biocompatibility of gel injection and degradation was evaluated in healthy human skin cultured ex vivo.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed I
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Site-Targeted

